400 related articles for article (PubMed ID: 19265111)
21. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells.
Cools N; Ponsaerts P; Van Tendeloo VF; Berneman ZN
J Leukoc Biol; 2007 Dec; 82(6):1365-74. PubMed ID: 17711977
[TBL] [Abstract][Full Text] [Related]
22. CD40L stimulation of rat dendritic cells specifically favors the IL-12/IL-10 ratio resulting in a strong T cell stimulatory capacity.
Stax AM; Crul C; Kamerling SW; Schlagwein N; van der Geest RN; Woltman AM; van Kooten C
Mol Immunol; 2008 May; 45(9):2641-50. PubMed ID: 18262271
[TBL] [Abstract][Full Text] [Related]
23. Involvement of CTLA-4 in T-cell anergy induced by staphylococcal enterotoxin A in vitro.
Xu GL; Zhu XH; Guo B; Wu YZ
Mol Immunol; 2004 May; 41(1):1-8. PubMed ID: 15140570
[TBL] [Abstract][Full Text] [Related]
24. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy.
Taams LS; van Eden W; Wauben MH
J Immunol; 1999 Feb; 162(4):1974-81. PubMed ID: 9973467
[TBL] [Abstract][Full Text] [Related]
25. Physiological concentrations of transforming growth factor beta1 selectively inhibit human dendritic cell function.
Fogel-Petrovic M; Long JA; Misso NL; Foster PS; Bhoola KD; Thompson PJ
Int Immunopharmacol; 2007 Dec; 7(14):1924-33. PubMed ID: 18039529
[TBL] [Abstract][Full Text] [Related]
26. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.
Kubsch S; Graulich E; Knop J; Steinbrink K
Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865
[TBL] [Abstract][Full Text] [Related]
27. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells.
Manavalan JS; Rossi PC; Vlad G; Piazza F; Yarilina A; Cortesini R; Mancini D; Suciu-Foca N
Transpl Immunol; 2003; 11(3-4):245-58. PubMed ID: 12967778
[TBL] [Abstract][Full Text] [Related]
28. Requirement of high-affinity IL-2-IL-2R interaction for T cell anergy induction.
Hayashi RJ; Kanagawa O
Int Immunol; 2006 May; 18(5):645-51. PubMed ID: 16574670
[TBL] [Abstract][Full Text] [Related]
29. Distinct subsets of human invariant NKT cells differentially regulate T helper responses via dendritic cells.
Liu TY; Uemura Y; Suzuki M; Narita Y; Hirata S; Ohyama H; Ishihara O; Matsushita S
Eur J Immunol; 2008 Apr; 38(4):1012-23. PubMed ID: 18350544
[TBL] [Abstract][Full Text] [Related]
30. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
31. CD28 and ICOS: similar or separate costimulators of T cells?
van Berkel ME; Oosterwegel MA
Immunol Lett; 2006 Jun; 105(2):115-22. PubMed ID: 16580736
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway.
Kuo PL; Hung JY; Huang SK; Chou SH; Cheng DE; Jong YJ; Hung CH; Yang CJ; Tsai YM; Hsu YL; Huang MS
J Immunol; 2011 Feb; 186(3):1521-30. PubMed ID: 21191065
[TBL] [Abstract][Full Text] [Related]
33. Gap junctions at the dendritic cell-T cell interface are key elements for antigen-dependent T cell activation.
Elgueta R; Tobar JA; Shoji KF; De Calisto J; Kalergis AM; Bono MR; Rosemblatt M; Sáez JC
J Immunol; 2009 Jul; 183(1):277-84. PubMed ID: 19542439
[TBL] [Abstract][Full Text] [Related]
34. The impact of cell-bound antigen transport on mucosal tolerance induction.
Pabst O; Bernhardt G; Förster R
J Leukoc Biol; 2007 Oct; 82(4):795-800. PubMed ID: 17565048
[TBL] [Abstract][Full Text] [Related]
35. Induction of human CD4+ regulatory T cells by mycophenolic acid-treated dendritic cells.
Lagaraine C; Lemoine R; Baron C; Nivet H; Velge-Roussel F; Lebranchu Y
J Leukoc Biol; 2008 Oct; 84(4):1057-64. PubMed ID: 18611986
[TBL] [Abstract][Full Text] [Related]
36. Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease?
Shilling RA; Bandukwala HS; Sperling AI
Clin Immunol; 2006 Oct; 121(1):13-8. PubMed ID: 16790364
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function.
Vlad G; Chang CC; Colovai AI; Berloco P; Cortesini R; Suciu-Foca N
Hum Immunol; 2009 May; 70(5):340-4. PubMed ID: 19275918
[TBL] [Abstract][Full Text] [Related]
38. AILIM/ICOS signaling induces T-cell migration/polarization of memory/effector T-cells.
Okamoto N; Nukada Y; Tezuka K; Ohashi K; Mizuno K; Tsuji T
Int Immunol; 2004 Oct; 16(10):1515-22. PubMed ID: 15339883
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro.
Beinhauer BG; McBride JM; Graf P; Pursch E; Bongers M; Rogy M; Korthauer U; de Vries JE; Aversa G; Jung T
Eur J Immunol; 2004 Jan; 34(1):74-80. PubMed ID: 14971032
[TBL] [Abstract][Full Text] [Related]
40. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
